Vanguard Group
ABUS icon

Vanguard Group’s Arbutus Biopharma ABUS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$28.1M Buy
9,085,086
+131,263
+1% +$406K ﹤0.01% 2395
2025
Q1
$31.2M Sell
8,953,823
-27,041
-0.3% -$94.4K ﹤0.01% 2298
2024
Q4
$29.4M Buy
8,980,864
+62,282
+0.7% +$204K ﹤0.01% 2398
2024
Q3
$34.3M Buy
8,918,582
+1,896,487
+27% +$7.3M ﹤0.01% 2342
2024
Q2
$21.7M Buy
7,022,095
+1,034,188
+17% +$3.2M ﹤0.01% 2528
2024
Q1
$15.4M Sell
5,987,907
-976
-0% -$2.52K ﹤0.01% 2722
2023
Q4
$15M Buy
5,988,883
+40,861
+0.7% +$102K ﹤0.01% 2726
2023
Q3
$12.1M Buy
5,948,022
+128,668
+2% +$261K ﹤0.01% 2774
2023
Q2
$13.4M Buy
5,819,354
+178,152
+3% +$410K ﹤0.01% 2786
2023
Q1
$17.1M Buy
5,641,202
+276,177
+5% +$837K ﹤0.01% 2657
2022
Q4
$12.5M Buy
5,365,025
+99,141
+2% +$231K ﹤0.01% 2848
2022
Q3
$10.1M Buy
5,265,884
+64,485
+1% +$123K ﹤0.01% 2952
2022
Q2
$14.1M Buy
5,201,399
+463,221
+10% +$1.26M ﹤0.01% 2810
2022
Q1
$14.1M Buy
4,738,178
+182,684
+4% +$544K ﹤0.01% 2966
2021
Q4
$17.7M Buy
4,555,494
+789,515
+21% +$3.07M ﹤0.01% 2907
2021
Q3
$16.2M Buy
3,765,979
+29,746
+0.8% +$128K ﹤0.01% 2977
2021
Q2
$11.3M Buy
3,736,233
+904,006
+32% +$2.74M ﹤0.01% 3137
2021
Q1
$9.43M Buy
2,832,227
+84,468
+3% +$281K ﹤0.01% 3176
2020
Q4
$9.76M Buy
2,747,759
+506,861
+23% +$1.8M ﹤0.01% 3008
2020
Q3
$7.02M Buy
2,240,898
+414,967
+23% +$1.3M ﹤0.01% 2977
2020
Q2
$3.32M Buy
1,825,931
+712,683
+64% +$1.3M ﹤0.01% 3270
2020
Q1
$1.12M Buy
1,113,248
+477,440
+75% +$482K ﹤0.01% 3460
2019
Q4
$1.77M Buy
635,808
+286,577
+82% +$797K ﹤0.01% 3484
2019
Q3
$533K Buy
349,231
+140,038
+67% +$214K ﹤0.01% 3804
2019
Q2
$435K Sell
209,193
-73,433
-26% -$153K ﹤0.01% 3856
2019
Q1
$1.01M Sell
282,626
-3,110
-1% -$11.1K ﹤0.01% 3624
2018
Q4
$1.09M Buy
285,736
+1,260
+0.4% +$4.82K ﹤0.01% 3545
2018
Q3
$2.69M Buy
284,476
+195,542
+220% +$1.85M ﹤0.01% 3433
2018
Q2
$650K Buy
+88,934
New +$650K ﹤0.01% 3783
2017
Q4
Sell
-78,634
Closed -$488K 4063
2017
Q3
$488K Buy
78,634
+1,221
+2% +$7.58K ﹤0.01% 3756
2017
Q2
$279K Buy
77,413
+2,035
+3% +$7.33K ﹤0.01% 3842
2017
Q1
$245K Buy
75,378
+888
+1% +$2.89K ﹤0.01% 3871
2016
Q4
$183K Buy
74,490
+925
+1% +$2.27K ﹤0.01% 3904
2016
Q3
$253K Buy
73,565
+7,489
+11% +$25.8K ﹤0.01% 3864
2016
Q2
$230K Sell
66,076
-7,991
-11% -$27.8K ﹤0.01% 3922
2016
Q1
$306K Buy
74,067
+1,617
+2% +$6.68K ﹤0.01% 3883
2015
Q4
$322K Buy
+72,450
New +$322K ﹤0.01% 3923